Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023
“Global embolic protection devices market projected to grow at a CAGR of 8.3%”
The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.
“By type & material, the distal filters market & nitinol market held the largest market share in 2017”
By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.
“By indication, the transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period”
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.
Break of primary participants was as mentioned below:
Research Coverage:
The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.
The report provides insights on the following pointers:
The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3% during the forecast period. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. However, product failure and recalls may restrain market growth to a certain extent.
“By type & material, the distal filters market & nitinol market held the largest market share in 2017”
By type, the global embolic protection devices market is segmented into distal filter devices, distal occlusion devices & proximal occlusion devices. By material, the global embolic protection devices market is segmented into plastic nitinol and polyurethane. In 2017, the distal filters segment dominated the embolic protection devices market by type and Nitinol dominated the embolic protection material market.
“By indication, the transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period”
On the basis of indication, the market is categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The transcatheter aortic valve replacement segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is driven by factors such as growing geriatric population, increasing obese population, increasing prevalence of aortic stenosis in heart patients, and rising demand for minimally invasive procedures.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the embolic protection devices market in 2017, followed by Europe. In North America, the US is expected to hold the largest share of the embolic protection devices market due to the rising prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding to develop novel products, and the strong presence of device manufacturers in the country.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–45%, Tier 2–30% and Tier 3–25%
- By Designation – C-level–45%, Director Level–32%, Others–23%
- By Region – North America–46%, Europe–27%, Asia-Pacific–20%, Latin America–4%, Middle East & Africa- 3%
Research Coverage:
The embolic protection devices market in this report is segmented by type & material, application, indication, end user, and region. It provides detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers, acquisitions, product development, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the embolic protection devices market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—market share analysis of top players and company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the embolic protection devices market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest industry statistics and trends, allowing buyers to identify the high-growth product segments, potential customers, and suppliers hence driving revenue growth and profitability.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on embolic devices offered by the top players in the global embolic protection devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the embolic protection devices market
- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for embolic protection devices market across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global embolic protection devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global embolic protection devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES IN THE EMBOLIC PROTECTION DEVICES MARKET
4.2 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION AND COUNTRY
4.3 GEOGRAPHIC SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
4.4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
4.5 EMBOLIC PROTECTION DEVICES MARKET: REGIONAL MIX
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of cardiovascular & neurovascular diseases
5.2.1.2 Funding and investments for r&d on embolic protection devices
5.2.1.3 Technological advancements
5.2.1.4 Rising demand for minimally invasive procedures
5.2.2 RESTRAINT
5.2.2.1 Product failure and recalls
5.2.3 OPPORTUNITIE
5.2.3.1 Growth opportunities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory scenario and unfavorable government policies
5.2.4.2 Dearth of skilled professionals
6 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE & MATERIAL
6.1 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE
6.1.1 DISTAL FILTER DEVICES
6.1.2 DISTAL OCCLUSION DEVICES
6.1.3 PROXIMAL OCCLUSION DEVICES
6.2 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL
6.2.1 NITINOL
6.2.2 POLYURETHANE
7 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CARDIOVASCULAR DISEASES
7.3 NEUROVASCULAR DISEASES
7.4 PERIPHERAL VASCULAR DISEASES
8 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION
8.1 INTRODUCTION
8.2 PERCUTANEOUS CORONARY INTERVENTION
8.3 CAROTID ARTERY DISEASES
8.4 SAPHENOUS VEIN GRAFT DISEASE
8.5 TRANSCATHER AORTIC VALVE REPLACEMENT
8.6 OTHER INDICATIONS
9 EMBOLIC PROTECTION DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.3 AMBULATORY SURGICAL CENTERS
10 EMBOLIC PROTECTION DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 SPAIN
10.3.5 ITALY
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.6 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 RANKING FOR PLAYERS, 2017
11.3 COMPETITIVE SCENARIO
11.3.1 ACQUISITIONS
11.3.2 PRODUCT LAUNCHES
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
11.3.4 EXPANSIONS
12 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 MEDTRONIC
12.2 ABBOTT LABORATORIES
12.3 BOSTON SCIENTIFIC
12.4 CORDIS (A CARDINAL HEALTH COMPANY)
12.5 CONTEGO MEDICAL
12.6 W. L. GORE & ASSOCIATES
12.7 SILK ROAD MEDICAL
12.8 CLARET MEDICAL
12.9 ALLIUM MEDICAL SOLUTIONS
12.10 ANGIOSLIDE
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES IN THE EMBOLIC PROTECTION DEVICES MARKET
4.2 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION AND COUNTRY
4.3 GEOGRAPHIC SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
4.4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE,
4.5 EMBOLIC PROTECTION DEVICES MARKET: REGIONAL MIX
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence of cardiovascular & neurovascular diseases
5.2.1.2 Funding and investments for r&d on embolic protection devices
5.2.1.3 Technological advancements
5.2.1.4 Rising demand for minimally invasive procedures
5.2.2 RESTRAINT
5.2.2.1 Product failure and recalls
5.2.3 OPPORTUNITIE
5.2.3.1 Growth opportunities in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory scenario and unfavorable government policies
5.2.4.2 Dearth of skilled professionals
6 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE & MATERIAL
6.1 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE
6.1.1 DISTAL FILTER DEVICES
6.1.2 DISTAL OCCLUSION DEVICES
6.1.3 PROXIMAL OCCLUSION DEVICES
6.2 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL
6.2.1 NITINOL
6.2.2 POLYURETHANE
7 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CARDIOVASCULAR DISEASES
7.3 NEUROVASCULAR DISEASES
7.4 PERIPHERAL VASCULAR DISEASES
8 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION
8.1 INTRODUCTION
8.2 PERCUTANEOUS CORONARY INTERVENTION
8.3 CAROTID ARTERY DISEASES
8.4 SAPHENOUS VEIN GRAFT DISEASE
8.5 TRANSCATHER AORTIC VALVE REPLACEMENT
8.6 OTHER INDICATIONS
9 EMBOLIC PROTECTION DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.3 AMBULATORY SURGICAL CENTERS
10 EMBOLIC PROTECTION DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 SPAIN
10.3.5 ITALY
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.6 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 RANKING FOR PLAYERS, 2017
11.3 COMPETITIVE SCENARIO
11.3.1 ACQUISITIONS
11.3.2 PRODUCT LAUNCHES
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
11.3.4 EXPANSIONS
12 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 MEDTRONIC
12.2 ABBOTT LABORATORIES
12.3 BOSTON SCIENTIFIC
12.4 CORDIS (A CARDINAL HEALTH COMPANY)
12.5 CONTEGO MEDICAL
12.6 W. L. GORE & ASSOCIATES
12.7 SILK ROAD MEDICAL
12.8 CLARET MEDICAL
12.9 ALLIUM MEDICAL SOLUTIONS
12.10 ANGIOSLIDE
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 EMBOLIC PROTECTION DEVICES MARKET: (IMPACT ANALYSIS)
Table 2 PRODUCT APPROVALS IN THE EMBOLIC PROTECTION DEVICES MARKET, 2014–2017
Table 3 PRODUCT RECALLS IN THE EMBOLIC PROTECTION DEVICES MARKET (2011–2016)
Table 4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 5 EMBOLIC PROTECTION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 6 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL FILTER DEVICES
Table 7 DISTAL FILTER DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 DISTAL FILTER DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 9 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL OCCLUSION DEVICES
Table 10 DISTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 DISTAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 12 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF PROXIMAL OCCLUSION DEVICES
Table 13 PROXIMAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 PROXIMAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 15 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 16 NITINOL EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 POLYURETHANE EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 19 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
Table 20 EMBOLIC PROTECTION DEVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF NEUROVASCULAR DISEASES
Table 22 EMBOLIC PROTECTION DEVICES MARKET FOR NEUROVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES
Table 24 EMBOLIC PROTECTION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 26 EMBOLIC PROTECTION DEVICES MARKET FOR PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 EMBOLIC PROTECTION DEVICES MARKET FOR CAROTID ARTERY DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 EMBOLIC PROTECTION DEVICES MARKET FOR SAPHENOUS VEIN GRAFT DISEASE, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 EMBOLIC PROTECTION DEVICES MARKET FOR TAVR, BY COUNTRY, 2016–2023 (USD MILLION)
Table 30 EMBOLIC PROTECTION DEVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 32 EMBOLIC PROTECTION DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 EMBOLIC PROTECTION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 40 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 41 US: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 42 US: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 43 US: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 44 US: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 45 US: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 46 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 47 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 48 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 50 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 51 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 52 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 53 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 54 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 56 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 58 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 59 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 60 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 61 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 62 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 63 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 64 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 65 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 66 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 67 UK: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 UK: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 69 UK: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 70 UK: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 71 UK: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 72 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 74 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 75 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 76 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 78 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 79 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 80 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 81 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 82 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 84 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 85 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 86 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 88 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 89 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 90 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 91 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 92 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 93 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 95 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 96 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 97 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 98 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 99 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 100 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 101 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 102 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 103 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 105 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 106 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 107 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 108 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 109 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 110 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 111 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 112 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 113 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 114 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 116 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 117 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 118 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 119 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 121 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 122 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 123 RANK OF COMPANIES IN THE GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2017
Table 124 KEY ACQUISITIONS, JANUARY 2015 – DECEMBER 2017
Table 125 KEY PRODUCT LAUNCHES, JANUARY 2015– DECEMBER 2017
Table 126 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2015 – DECEMBER 2017
Table 127 KEY EXPANSIONS, JANUARY 2015 – DECEMBER 2017
Table 1 EMBOLIC PROTECTION DEVICES MARKET: (IMPACT ANALYSIS)
Table 2 PRODUCT APPROVALS IN THE EMBOLIC PROTECTION DEVICES MARKET, 2014–2017
Table 3 PRODUCT RECALLS IN THE EMBOLIC PROTECTION DEVICES MARKET (2011–2016)
Table 4 EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 5 EMBOLIC PROTECTION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 6 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL FILTER DEVICES
Table 7 DISTAL FILTER DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 8 DISTAL FILTER DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 9 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF DISTAL OCCLUSION DEVICES
Table 10 DISTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 DISTAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 12 APPLICATIONS AND ADVANTAGES/DISADVANTAGES OF PROXIMAL OCCLUSION DEVICES
Table 13 PROXIMAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 14 PROXIMAL OCCLUSION DEVICES MARKET, BY VOLUME, 2016–2023 (THOUSAND UNITS)
Table 15 EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 16 NITINOL EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 POLYURETHANE EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 19 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES
Table 20 EMBOLIC PROTECTION DEVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF NEUROVASCULAR DISEASES
Table 22 EMBOLIC PROTECTION DEVICES MARKET FOR NEUROVASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 EMBOLIC PROTECTION DEVICES USED IN THE TREATMENT OF PERIPHERAL VASCULAR DISEASES
Table 24 EMBOLIC PROTECTION DEVICES MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 26 EMBOLIC PROTECTION DEVICES MARKET FOR PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 EMBOLIC PROTECTION DEVICES MARKET FOR CAROTID ARTERY DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 EMBOLIC PROTECTION DEVICES MARKET FOR SAPHENOUS VEIN GRAFT DISEASE, BY COUNTRY, 2016–2023 (USD MILLION)
Table 29 EMBOLIC PROTECTION DEVICES MARKET FOR TAVR, BY COUNTRY, 2016–2023 (USD MILLION)
Table 30 EMBOLIC PROTECTION DEVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 32 EMBOLIC PROTECTION DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 33 EMBOLIC PROTECTION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 39 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 40 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 41 US: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 42 US: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 43 US: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 44 US: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 45 US: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 46 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 47 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 48 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 49 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 50 CANADA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 51 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 52 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 53 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 54 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 55 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 56 EUROPE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 57 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 58 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 59 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 60 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 61 GERMANY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 62 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 63 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 64 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 65 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 66 FRANCE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 67 UK: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 68 UK: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 69 UK: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 70 UK: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 71 UK: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 72 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 73 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 74 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 75 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 76 SPAIN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 77 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 78 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 79 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 80 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 81 ITALY: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 82 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 83 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 84 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 85 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 86 ROE: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 87 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 88 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 89 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 90 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 91 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 92 APAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 93 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 94 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 95 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 96 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 97 JAPAN: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 98 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 99 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 100 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 101 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 102 CHINA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 103 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 104 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 105 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 106 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 107 INDIA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 108 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 109 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 110 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 111 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 112 ROAPAC: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 113 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 114 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 116 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 117 LATIN AMERICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 118 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 119 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY MATERIAL, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 121 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY INDICATION, 2016–2023 (USD MILLION)
Table 122 MIDDLE EAST & AFRICA: EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 123 RANK OF COMPANIES IN THE GLOBAL EMBOLIC PROTECTION DEVICES MARKET, 2017
Table 124 KEY ACQUISITIONS, JANUARY 2015 – DECEMBER 2017
Table 125 KEY PRODUCT LAUNCHES, JANUARY 2015– DECEMBER 2017
Table 126 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, JANUARY 2015 – DECEMBER 2017
Table 127 KEY EXPANSIONS, JANUARY 2015 – DECEMBER 2017
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 DATA TRIANGULATION
Figure 3 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION)
Figure 4 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT MATERIAL, 2018 VS. 2023 (USD MILLION)
Figure 5 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 6 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 7 EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 8 GEOGRAPHICAL SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
Figure 9 RISING INCIDENCE OF CARDIOVASCULAR AND NEUROVASCULAR DISEASES IS DRIVING MARKET GROWTH
Figure 10 JAPAN ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
Figure 11 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE EMBOLIC PROTECTION DEVICES MARKET IN 2017
Figure 12 DISTAL FILTER DEVICES WILL CONTINUE TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET IN 2018-2023
Figure 13 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035
Figure 15 DISTAL FILTER DEVICES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 16 NITINOL IS PROJECTED TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 17 CARDIOVASCULAR DISEASES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 18 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 19 EMBOLIC PROTECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
Figure 20 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 21 EUROPE: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 22 APAC: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 23 KEY DEVELOPMENTS IN THE EMBOLIC PROTECTION DEVICES MARKET BETWEEN 2014 AND 2017
Figure 24 MEDTRONIC: COMPANY SNAPSHOT
Figure 25 ABBOTT LABORATORIES: COMPANY SNAPSHOT
Figure 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
Figure 27 CARDINAL HEALTH: COMPANY SNAPSHOT
Figure 28 ALLIUM MEDICAL SOLUTIONS: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN
Figure 2 DATA TRIANGULATION
Figure 3 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT TYPE, 2018 VS. 2023 (USD MILLION)
Figure 4 EMBOLIC PROTECTION DEVICES MARKET, BY PRODUCT MATERIAL, 2018 VS. 2023 (USD MILLION)
Figure 5 EMBOLIC PROTECTION DEVICES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 6 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 7 EMBOLIC PROTECTION DEVICES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 8 GEOGRAPHICAL SNAPSHOT OF THE EMBOLIC PROTECTION DEVICES MARKET
Figure 9 RISING INCIDENCE OF CARDIOVASCULAR AND NEUROVASCULAR DISEASES IS DRIVING MARKET GROWTH
Figure 10 JAPAN ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
Figure 11 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE EMBOLIC PROTECTION DEVICES MARKET IN 2017
Figure 12 DISTAL FILTER DEVICES WILL CONTINUE TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET IN 2018-2023
Figure 13 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 PREVALENCE OF CARDIOVASCULAR DISEASES, 2015–2035
Figure 15 DISTAL FILTER DEVICES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 16 NITINOL IS PROJECTED TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 17 CARDIOVASCULAR DISEASES TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 18 PERCUTANEOUS CORONARY INTERVENTION SEGMENT TO DOMINATE THE EMBOLIC PROTECTION DEVICES MARKET DURING THE FORECAST PERIOD
Figure 19 EMBOLIC PROTECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
Figure 20 NORTH AMERICA: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 21 EUROPE: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 22 APAC: EMBOLIC PROTECTION DEVICES MARKET SNAPSHOT
Figure 23 KEY DEVELOPMENTS IN THE EMBOLIC PROTECTION DEVICES MARKET BETWEEN 2014 AND 2017
Figure 24 MEDTRONIC: COMPANY SNAPSHOT
Figure 25 ABBOTT LABORATORIES: COMPANY SNAPSHOT
Figure 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
Figure 27 CARDINAL HEALTH: COMPANY SNAPSHOT
Figure 28 ALLIUM MEDICAL SOLUTIONS: COMPANY SNAPSHOT
